Osong, South Korea, 1 Oct 2025 – The Sarawak Biodiversity Council and the Osong Medical Innovation Foundation (KBIOHealth) have signed a Memorandum of Understanding (MoU) to collaborate in areas of biotechnology, focusing on joint research and development (R&D), regulatory collaboration, and Good Manufacturing Practice (GMP) compliance. The MoU was signed by Council Chairman, Dato Sri Dr. Muhammad Abdullah Bin Haji Zaidel, and KBIOHealth Chairman and CEO, Mr. Lee Myung-su.
The MoU exchange ceremony, held at the Osong Medical Innovation Foundation Complex in South Korea on 30th September 2025, marks a significant milestone in Sarawak’s efforts to build a competitive biotechnology ecosystem and expand its presence in the global bioeconomy.
The event included a working visit to KBIOHealth’s New Drug Development Center, Non-Clinical Evaluation and Biopharmaceutical Manufacturing Center – a world-class biomedical research and production facilities.
“We aimed to work together with KBIO on a joint R&D for pre-clinical testing and production of bioproducts. Today’s MoU is to benefit both the Sarawak Biodiversity Centre (SBC) and KBIO” said Dato Sri Dr. Muhammad Abdullah.
In his welcoming remarks, Mr. Lee mentioned that “through this MOU, I really wish to develop international industry and also hope to further implement our MOU”.
The ceremony was attended by Tuan Haji Adana bin Haji Jed, Permanent Secretary to the Ministry of Education, Innovation and Talent Development (MEITD), Dato Dr Yeo Tiong Chia, Chief Executive Officer of SBC, Datu Jack anak Liam, Controller of Environmental Quality Sarawak, Mr Dominic anak Chunggat, Director of the Department of Agriculture, Dr Mary Jane Cardosa, Chief Technical Officer of Integrated Research Associates LLC, Mdm Anne Kung Soo Ching, Chief Executive Officer of Instacom Engineering Sdn Bhd, and Ts. Hazwan bin Razak, Chief Executive Officer of BioVerde Technologies Sdn Bhd (BVT). Representing KBIOHealth were Kim Hyunil, Bio Pharmaceuticals Manufacturing Centre and Kim Seunghyun, Management Support Team.
The Osong Medical Innovation Foundation (KBIOHealth) is a leading public institution in South Korea dedicated to advancing biomedical innovation. Located within the Osong High-Tech Medical Complex in North Chungcheong Province, KBIOHealth offers comprehensive services including pre-clinical testing, regulatory support, and GMP biomanufacturing. Since 2022, it has also provided specialised biopharma training programmes to build a skilled workforce and strengthen the biotechnology sector
